FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890904879> ?p ?o ?g. }

• W2890904879 abstract "Antimicrobial peptides (AMPs) are multifunctional factors with an important role in the innate immune system. Our previous studies revealed that the human cathelicidin LL‑37 and its analog, FF/CAP18, limit the proliferation of colon cancer cell lines. In the present study, the exosomes released by HCT116 cells treated with FF/CAP18 were analyzed. After the treatment, exosomes were isolated from the culture supernatant by ultrafiltration and using the miRCURY™ Exosome Isolation Kit. Membrane vesicles 40‑100‑nm expressing CD63 and CD81 were identified before and after FF/CAP18 treatment. Exosome concentration in the culture supernatant was increased after treatment with FF/CAP18. Exosomes formed in HCT116 cells treated with FF/CAP18 induced growth suppression of the cells in a dose‑dependent manner. By contrast, the exosomes formed in non‑treated HCT116 cells did not affect cell viability. Microarray analysis of miRNA expression indicated that FF/CAP18 treatment induced increases in the expression of three miRNAs (miR‑584‑5p, miR‑1202 and miR‑3162‑5p) in both HCT116 cells and exosomes. These results suggest that FF/CAP18 treatment increases exosome formation, and that exosome‑encapsulated miRNAs suppress HCT116 cell proliferation. Exosomal miRNAs are considered to be involved in the dissemination of cell signals to control local cellular microenvironments. The present findings suggest that FF/CAP18 regulates cancer growth by modulating cell‑to‑cell communication. AMPs localize in the cytoplasm of cancer cells and enhance the expression of growth‑suppressing miRNAs. These miRNAs are also transported to other cancer cells via exosomes. Therefore, transportation of these miRNAs has the potential to suppress cancer growth. AMPs exert their effects directly by targeting cancer cells and indirectly via exosomes." @default.
• W2890904879 created "2018-09-27" @default.
• W2890904879 creator A5018807384 @default.
• W2890904879 creator A5026797354 @default.
• W2890904879 creator A5053717782 @default.
• W2890904879 creator A5080973494 @default.
• W2890904879 creator A5090764102 @default.
• W2890904879 date "2018-09-13" @default.
• W2890904879 modified "2023-10-01" @default.
• W2890904879 title "Suppressive effect of an analog of the antimicrobial peptide of LL‑37 on colon cancer cells via exosome‑encapsulated miRNAs" @default.
• W2890904879 cites W1520340830 @default.
• W2890904879 cites W1591729514 @default.
• W2890904879 cites W1648301895 @default.
• W2890904879 cites W1964113525 @default.
• W2890904879 cites W1968928247 @default.
• W2890904879 cites W1975525930 @default.
• W2890904879 cites W1986224819 @default.
• W2890904879 cites W1992970284 @default.
• W2890904879 cites W2002995168 @default.
• W2890904879 cites W2005424571 @default.
• W2890904879 cites W2019858243 @default.
• W2890904879 cites W2027974886 @default.
• W2890904879 cites W2028445515 @default.
• W2890904879 cites W2029331076 @default.
• W2890904879 cites W2030701238 @default.
• W2890904879 cites W2031204755 @default.
• W2890904879 cites W2048146059 @default.
• W2890904879 cites W2055313665 @default.
• W2890904879 cites W2055791162 @default.
• W2890904879 cites W2076253721 @default.
• W2890904879 cites W2090407536 @default.
• W2890904879 cites W2100266303 @default.
• W2890904879 cites W2112785261 @default.
• W2890904879 cites W2114021667 @default.
• W2890904879 cites W2127449370 @default.
• W2890904879 cites W2133024763 @default.
• W2890904879 cites W2141390429 @default.
• W2890904879 cites W2143839116 @default.
• W2890904879 cites W2398542230 @default.
• W2890904879 cites W2443842974 @default.
• W2890904879 cites W2558558076 @default.
• W2890904879 cites W2568531117 @default.
• W2890904879 cites W2606114225 @default.
• W2890904879 cites W2607776572 @default.
• W2890904879 cites W2917837889 @default.
• W2890904879 doi "https://doi.org/10.3892/ijmm.2018.3875" @default.
• W2890904879 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6202099" @default.
• W2890904879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30221678" @default.
• W2890904879 hasPublicationYear "2018" @default.
• W2890904879 type Work @default.
• W2890904879 sameAs 2890904879 @default.
• W2890904879 citedByCount "6" @default.
• W2890904879 countsByYear W28909048792019 @default.
• W2890904879 countsByYear W28909048792021 @default.
• W2890904879 countsByYear W28909048792022 @default.
• W2890904879 countsByYear W28909048792023 @default.
• W2890904879 crossrefType "journal-article" @default.
• W2890904879 hasAuthorship W2890904879A5018807384 @default.
• W2890904879 hasAuthorship W2890904879A5026797354 @default.
• W2890904879 hasAuthorship W2890904879A5053717782 @default.
• W2890904879 hasAuthorship W2890904879A5080973494 @default.
• W2890904879 hasAuthorship W2890904879A5090764102 @default.
• W2890904879 hasBestOaLocation W28909048791 @default.
• W2890904879 hasConcept C104317684 @default.
• W2890904879 hasConcept C121608353 @default.
• W2890904879 hasConcept C136449434 @default.
• W2890904879 hasConcept C145059251 @default.
• W2890904879 hasConcept C1491633281 @default.
• W2890904879 hasConcept C203014093 @default.
• W2890904879 hasConcept C20518536 @default.
• W2890904879 hasConcept C2777379352 @default.
• W2890904879 hasConcept C2781261824 @default.
• W2890904879 hasConcept C29537977 @default.
• W2890904879 hasConcept C502942594 @default.
• W2890904879 hasConcept C54355233 @default.
• W2890904879 hasConcept C55493867 @default.
• W2890904879 hasConcept C62112901 @default.
• W2890904879 hasConcept C81885089 @default.
• W2890904879 hasConcept C86803240 @default.
• W2890904879 hasConcept C8891405 @default.
• W2890904879 hasConcept C95444343 @default.
• W2890904879 hasConcept C96232424 @default.
• W2890904879 hasConceptScore W2890904879C104317684 @default.
• W2890904879 hasConceptScore W2890904879C121608353 @default.
• W2890904879 hasConceptScore W2890904879C136449434 @default.
• W2890904879 hasConceptScore W2890904879C145059251 @default.
• W2890904879 hasConceptScore W2890904879C1491633281 @default.
• W2890904879 hasConceptScore W2890904879C203014093 @default.
• W2890904879 hasConceptScore W2890904879C20518536 @default.
• W2890904879 hasConceptScore W2890904879C2777379352 @default.
• W2890904879 hasConceptScore W2890904879C2781261824 @default.
• W2890904879 hasConceptScore W2890904879C29537977 @default.
• W2890904879 hasConceptScore W2890904879C502942594 @default.
• W2890904879 hasConceptScore W2890904879C54355233 @default.
• W2890904879 hasConceptScore W2890904879C55493867 @default.
• W2890904879 hasConceptScore W2890904879C62112901 @default.
• W2890904879 hasConceptScore W2890904879C81885089 @default.
• W2890904879 hasConceptScore W2890904879C86803240 @default.
• W2890904879 hasConceptScore W2890904879C8891405 @default.
• W2890904879 hasConceptScore W2890904879C95444343 @default.

• next